BioSpace News Archive

Disposable medical gloves refer to those gloves that are utilized at the time of various medical procedures and examinations in a bid to avoid any kind of cross-contamination between patients and caregivers.

The global healthcare contract research outsourcing market was valued at US$ 30.0 Bn in 2016 and is projected to expand at a cumulative annual growth rate of 6.8% from 2017 to 2025 according to a new report published by Transparency Market Research

Healthcare 3D printing, which is also called bioprinting, was considered a dream a few decades before.

The global healthcare IT market is brimming with opportunities as health information technology has revolutionized patient care and healthcare services across the world.

Haemophilus influenza type b (Hib) is a bacterium which causes several diseases such as pneumonia, epiglottitis, meningitis, and sepsis mostly in children younger than 5 years

Immunovia AB announced that the results of the current study in lung cancer strongly supports an expansion into the next stage in the discovery process.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced that Vu Truong, Ph.D., Chief Executive Officer, will participate in Cantor Fitzgerald’s Virtual Symposium: “Winning Ways to Treat Infections and COVID-19" being held on Tuesday, June 30, 2020.

Keros Therapeutics, Inc. announced that the Company is set to join the Russell 2000® Index, effective after the close of the U.S. markets on June 26, 2020.

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announces its unaudited financial results for the first quarter ended March 31, 2020.

Axsome Therapeutics, Inc., a biopharmaceutical company developing novel therapies for the management of central nervous system disorders, announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation for AXS-05 for the treatment of Alzheimer’s disease agitation.